Omnichannel is the most overused word in pharma commercial strategy. Every brand plan has an omnichannel section. Few brand teams can articulate what omnichannel actually means for their specific prescriber population, their specific asset, and their specific commercial infrastructure. The gap between the slides and the execution is where most programs fall apart.
What Omnichannel Is Not
Omnichannel is not multichannel. Running a rep program alongside digital ads alongside an email nurture sequence is multichannel — it’s parallel channels with independent content and cadences. Omnichannel means those channels are coordinated: the physician who watched a scientific webinar gets a follow-up rep call that references it; the HCP who opened an email about a new clinical trial gets invited to an MSL roundtable; the one who hasn’t engaged digitally in 90 days gets a different set of touchpoints than the one who has.
True omnichannel requires data infrastructure that most pharma companies do not have. CRM systems that unify field, digital, and medical affairs touchpoints at the HCP level are a prerequisite. Real-time data visibility — so the field force knows what digital interactions have occurred before they make a call — is not standard. The investment required to build this infrastructure is substantial and takes longer than a single launch cycle to realize.
What Actually Moves Prescriber Behavior
The channel hierarchy in pharma HCP engagement is fairly consistent across categories: peer-to-peer influence — whether through KOL programs, MSL scientific exchanges, or advisory boards — drives the deepest behavior change. Rep calls, when they provide genuine clinical value and reach physicians who are accessible, are the second tier. Digital channels — email, programmatic, web content — are effective for awareness and reinforcement, but rarely generate new prescribing behavior on their own.
The implication for omnichannel planning: digital channels should be designed to amplify what the field and medical channels are doing, not to replace them. An email that reinforces a clinical message the physician just heard from their trusted peer is a different asset than an email introducing a message for the first time. Content sequencing — not just channel sequencing — is where the real omnichannel planning happens.
Segmentation Is the Foundation
Omnichannel only works at scale if the prescriber universe is intelligently segmented. Not every physician in your target list should receive the same touchpoint mix. High-decile specialists with active clinical interest in your disease area deserve field investment and MSL access. Low-decile primary care physicians who refer to specialists deserve a digital-first model with field touches reserved for practice visits when prescribing behavior changes.
The segmentation criteria that actually predict engagement vary by category and by the structure of the referral network. Investing in understanding how treatment decisions flow through your specific market — who influences whom, where the decisions actually get made — before designing the channel architecture is more valuable than any technology investment.
The Metrics That Matter
Most pharma omnichannel programs are measured on activity metrics — open rates, click-through rates, call completion rates, digital impressions served. These measure channel performance, not commercial impact. The metrics that matter are the ones that connect channel activity to prescribing behavior: new-to-brand writers, time-to-first-prescription in key accounts, patient persistence rates, and formulary exception rates by prescriber segment.
Building the measurement architecture to connect channel activity to commercial outcomes is hard and requires data linkage that most pharma companies are still developing. But until those connections exist, omnichannel programs are built on assumptions about what’s working — and assumptions have a way of surviving longer than they should when the measurement infrastructure doesn’t challenge them.
Related: HCP Engagement & Medical Affairs Hub | Commercial Launch Strategy Hub
